跳至主要内容
临床试验/NCT04165499
NCT04165499已完成早期 1 期

Preliminary Study of Nutritional Intervention, Randomized, Double Blind, and Controlled Parallel Groups to Evaluate the Effect of Consuming a Combination of of Plant Extracts (BSL_EP026) on Serum Uric Acid in Hypeuricemic Subjects.

Biosearch S.A.2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2019年11月11日最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
34
试验地点
2
主要终点
Uric acid

研究概览

简要总结

The objective of this study is to evaluate the effect of the combination of a combination of plant extracts (BSL_EP026) on blood and urine uricemia levels in individuals with levels at the limit of the values considered normal or moderately high.

详细描述

Hyperuricemia is an abnormally high level of uric acid in the blood, resulted because of an increased production of uric acid, decreased excretion of uric acid, or both. This can cause gout and nephrolithiasis, and it has also been related to metabolic syndrome, diabetes mellitus, cardiovascular disease and chronic kidney disease.

Some plant extracts have diuretic activity that could contribute to improve uric acid excretion. This effect would lead to a decrease in uric acid plasma levels and, secondarily, to an action on its metabolic pathway of endogenous biogeneration.

On the other hand, uric acid has a double reabsorption-elimination step in the renal tubules and the flavonoids of both extracts impede the processes of renal resorption promoting urinary elimination, in addition to increase the pH of the urine (higher than pH 5.8), which favors the non-precipitation or formation of urate stones.

Finally, the routine (present in the used extracts) inhibit the uric acid formation pathway from purines, which would act synergistically.

In this project, the effect of the intake of a combination plant extracts on uricemia levels will be studied.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Blood uric acid levels greater than 7 mg/dL in men and 6 mg dL in women.
  • Accept freely to participate in the study and sign the informed consent document.

排除标准

  • Having treatment that can affect uric acid levels.
  • Use of diuretics.
  • Follow a low purine diet.
  • Take a food supplement or drug that interferes with uric acid metabolism and renal system function.
  • Have an allergy to birch and/or orthosiphon or another component of the test products.
  • Low compliance expectation.

结局指标

主要结局

Uric acid

时间窗: 2 weeks

Uric acid in plasma

次要结局

  • Blood pressure(2 weeks)
  • pH of urine(2 weeks)
  • Fractional clearance of urate (FCU)(2 weeks)
  • Uric acid in urine(2 weeks)

研究者

发起方
Biosearch S.A.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验